€
159.10
Change
-0.75 -0.47%
Volume
Volume 18,401
Nov 28, 2023, 10:16 a.m.
Quotes are delayed by 20 min
Previous close
€ 159.85
€ 159.10
Change
-0.75 -0.47%
Day low
Day high
€158.40
€159.85

52 week low
52 week high
€135.00
€202.80

Market cap
€69.89B
Average volume
312,505
P/E ratio
23.90
Rev. per Employee
€333,603
EPS
6.66
Dividend
2.20
Div yield
1.38%
Ex dividend date
5/2/23
MarketWatch News on MRK
-
Stock market just can’t break through this key resistance level
- Lawrence G. McMillan
-
- Barron's Online
-
Positive Lilly cancer drug trial among ASCO releases
- MarketWatch.com
-
Bayer raises euro/dollar average exchange rate estimate for 2008
- MarketWatch.com
-
Matrix Labs may sell European generics unit Docpharma
- MarketWatch.com
-
Glenmark Pharma says Merck has quit pact on diabetes drug
- MarketWatch.com
-
Merck KGaA third-quarter net falls on Serono costs
- MarketWatch.com
-
ImClone, Bristol-Myers sign Erbitux pact with Merck in Japan
- MarketWatch.com
-
Mylan Labs' proposed buy of Merck unit challenged by FTC
- MarketWatch.com
-
Merck KGaA's second-quarter sales rise, but profit falls on Serono buy
- MarketWatch.com
-
Erbitux has modest benefit as first-line colorectal cancer drug
- MarketWatch.com
Other News on MRK
-
Roche’s Immunotherapy Drug Extended Patients’ Lives
- The Wall Street Journal Interactive Edition
-
Overheard: Bristol-Myers Zigs While Market Zags
- The Wall Street Journal Interactive Edition
-
Germany’s Merck Cautious After Deal Spree
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Europe Stimulus’s Winner? Germany
- The Wall Street Journal Interactive Edition
-
Astra’s Shaky Bridge to Pipeline’s Promise
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Pfizer, Germany’s Merck to Develop Tumor Treatment
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Germany’s Merck Nudges Sales Forecast Higher
- The Wall Street Journal Interactive Edition
-
German Drug Firms Target China
- The Wall Street Journal Interactive Edition
-
Merck Bond Shows Maturing European Market
- The Wall Street Journal Interactive Edition
-
European Stocks Recover From Two-Day Selloff
- The Wall Street Journal Interactive Edition
-
German Firms Go on U.S. Buying Spree
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
-
Germany's Merck to Buy Sigma-Aldrich
- The Wall Street Journal Interactive Edition
-
Germany's Merck Expands Tool Set
- The Wall Street Journal Interactive Edition
-
Germany's Merck Still Lacks Direction
- The Wall Street Journal Interactive Edition
-
- The Wall Street Journal Interactive Edition
- Loading more headlines...
Press Releases on MRK
No News currently available for MRK
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com